← All trials

NCT06149559

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 31, 2024
Primary completion
Jun 8, 2026
Completion date
Aug 17, 2026
First posted
Nov 29, 2023
Last posted
Dec 28, 2023
Enrollment
12
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

  • UCBLead sponsor

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.